BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
47 results:

  • 1. Risk of Metabolic Syndrome and Fatty Liver Diseases in gastric cancer Survivors: A Propensity Score-Matched Analysis.
    Han SJ; Baik SJ; Yoon YH; Kim JH; Lee HS; Jeon S; Park H
    Korean J Gastroenterol; 2023 Apr; 81(4):154-162. PubMed ID: 37096435
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Resistance to atr Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
    O'Leary PC; Chen H; Doruk YU; Williamson T; Polacco B; McNeal AS; Shenoy T; Kale N; Carnevale J; Stevenson E; Quigley DA; Chou J; Feng FY; Swaney DL; Krogan NJ; Kim M; Diolaiti ME; Ashworth A
    Cancer Res; 2022 Nov; 82(21):3950-3961. PubMed ID: 36273492
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
    Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
    Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
    [No Abstract]    [Full Text] [Related]  

  • 4. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through atr/CHK1 signaling in gastric cancer.
    Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
    Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Jolkinolide B induces cell cycle arrest and apoptosis in MKN45 gastric cancer cells and inhibits xenograft tumor growth in vivo.
    Zhang H; Qian J; Jin M; Fan L; Fan S; Pan H; Li Y; Wang N; Jian B
    Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35674158
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
    El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
    J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Olaparib-induced Apoptosis Through EBNA1-atr-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive gastric cancer Cells.
    Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
    Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling.
    Chang TY; Nepali K; Chen YY; Yang YSH; Hsu KC; Yen Y; Pan SL; Liou JP; Lee SB
    Biomed Pharmacother; 2021 Jun; 138():111485. PubMed ID: 33740521
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of Partially Covered Self-Expandable Metallic Stents for Esophageal cancer treatment:
    Chytrosz P; Golda-Cepa M; Wlodarczyk J; Kuzdzal J; El Fray M; Kotarba A
    ACS Biomater Sci Eng; 2021 Apr; 7(4):1403-1413. PubMed ID: 33709689
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
    Ding YL; Sun SF; Zhao GL
    Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hydrogen peroxide and Helicobacter pylori extract treatment combined with APE1 knockdown induce DNA damage, G2/M arrest and cell death in gastric cancer cell line.
    Manoel-Caetano FS; Rossi AFT; Ribeiro ML; Prates J; Oliani SM; Silva AE
    DNA Repair (Amst); 2020 Dec; 96():102976. PubMed ID: 33065487
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017.
    Huang SY; Chen HM; Liao KH; Ko BS; Hsiao FY
    BMJ Open; 2020 Oct; 10(10):e036341. PubMed ID: 33039986
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas.
    Ao L; Li L; Sun H; Chen H; Li Y; Huang H; Wang X; Guo Z; Zhou R
    BMC Gastroenterol; 2020 Jul; 20(1):233. PubMed ID: 32689938
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Laparoscopic versus open surgery for gastric gastrointestinal stromal tumors in unfavorable location: a propensity score-matching analysis].
    Tao KX; Wan WZ; Chen JH; Yang WC; Cai M; Shuai XM; Cai KL; Gao JB; Wang GB; Zhang P
    Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):585-590. PubMed ID: 31422627
    [No Abstract]    [Full Text] [Related]  

  • 18. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
    Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
    World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and atr inhibition identified using mass spectrometry and immunohistochemistry.
    Jones GN; Rooney C; Griffin N; Roudier M; Young LA; Garcia-Trinidad A; Hughes GD; Whiteaker JR; Wilson Z; Odedra R; Zhao L; Ivey RG; Howat WJ; Harrington EA; Barrett JC; Ramos-Montoya A; Lau A; Paulovich AG; Cadogan EB; Pierce AJ
    Br J Cancer; 2018 Nov; 119(10):1233-1243. PubMed ID: 30385821
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Comprehensive Human gastric cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.
    Yan HHN; Siu HC; Law S; Ho SL; Yue SSK; Tsui WY; Chan D; Chan AS; Ma S; Lam KO; Bartfeld S; Man AHY; Lee BCH; Chan ASY; Wong JWH; Cheng PSW; Chan AKW; Zhang J; Shi J; Fan X; Kwong DLW; Mak TW; Yuen ST; Clevers H; Leung SY
    Cell Stem Cell; 2018 Dec; 23(6):882-897.e11. PubMed ID: 30344100
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.